From alcohol toxicity to treatment

Alcoholism: Clinical and Experimental Research

Volumn 29, Issue 7, 2005, Pages 1341-1350

  Seitz, Helmut K ^a,i   Salaspuro, Mikko ^b   Savolainen, Markku ^c   Haber, Paul ^d   Ishii, Hiromasa ^e   Teschke, Rolf ^f   Moshage, Hans ^g   Lieber, Charles S ^h  

^a Krankenhaus Salem   (Germany)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e KEIO UNIVERSITY   (Japan)

^f City Hospital Hanau   (Germany)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acetaldehyde; Alcoholic Hepatitis; Annexin A2; Cholestasis; Cytochrome P4502E1; Gastrointestinal Bacteria; Hepatic Fibrogenesis; Hepatic Transcriptome; Hepatocellular Carcinoma; Microsomal Ethanol Oxidizing System; Phosphatidylethanol

Indexed keywords

ACETALDEHYDE; ALCOHOL; PHOSPHATIDYLETHANOLAMINE; TRANSCRIPTOME;

ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ALCOHOL LIVER DISEASE; ALLELE; AUSTRALIA; CANCER; CANCER RISK; CARCINOGENESIS; CHOLESTATIC HEPATITIS; CONFERENCE PAPER; CONTINUING EDUCATION; DIGESTIVE SYSTEM CANCER; GASTROINTESTINAL TRACT; GERMANY; HOMOZYGOSITY; HUMAN; LARGE INTESTINE; LIVER; LIVER FIBROSIS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; SALIVA;

ACETALDEHYDE; ALCOHOL DEHYDROGENASE; ALCOHOL-RELATED DISORDERS; ALCOHOLISM; ALLELES; CHOLESTASIS, INTRAHEPATIC; CYTOCHROME P-450 CYP2E1; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIVER DISEASES, ALCOHOLIC; METABOLIC DETOXICATION, DRUG; NEOPLASMS; RISK;

EID: 23044512527     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2005.tb03472.x     Document Type: Conference Paper

References (66)

1. Ahmed S, Leo MA, Lieber CS (1994) Interactions between alcohol and beta-carotene in patients with alcoholic liver diseases. Am J Clin Nutr 60:430-436.
2. Aleynik MK, Leo MA, Aleynik SI, Lieber CS (1999) Polyenylphosphatidylcholine opposes the increase of cytochrome P4502E1 by ethanol and corrects its iron-induced decrease. Alcohol Clin Exp Res 23:96-100.
3. Aleynik MK, CS Lieber (2001) Dilinoleoylphophatidylcholine decreases ethanol-induced cytochrome P4502E1. Biochem Biophys Res Commun 288:1047-1051.
4. Black D, Bird MA, Samson CM, Lyman S, Lange PA, Schrum LW, Qian T, Lemasters JJ, Brenner DA, Behrns KE (2004) Primary cirrhotic hepatocytes resist TGF-β-induced apoptosis through a ROS-dependent mechanism. J Hepatol 40:942-951.
5. Casini A, Cunningham M, Rojkind M, Lieber CS (1991) Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 13:758-765.
6. Falcone DJ, Borth W, Khan, KMF, Hajjar KA (2001) Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II. Blood 97:774-784.
7. Gujral JS, Liu J, Farhood A, Jaeschke H (2004) Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation. Hepatology 40:998-1007.
8. Hannuksela ML, Rämet ME, Nissinen AET, Liisanantti MK, Savolainen MJ (2004) Effects of ethanol on lipids and atherosclerosis. Pathophysiology 10:93-103.
9. Hasumura Y, Teschke R, Lieber CS (1976) Characteristics of acetaldehyde oxidation in rat liver mitochondria. J Biol Chem 251:4908-4913.
10. Homann N, Jousimies-Somer H, Jokelainen K, Heine R, Salaspuro M (1997) High acetaldehyde levels in saliva after ethanol consumption: Methodological aspects and pathogenetic implications. Carcinogenesis 18:1739-1743.
11. Homann N, Tillonen J, Meurman JH., Rintamäki H, Lindqvist C, Rautio M, Jousimies-Somer H, Salaspuro M (2000) Increased salivary acetaldehyde levels in heavy drinkers and smokers: a microbiological approach to oral cavity cancer. Carcinogenesis 22:663-668.
12. Homann N, Tillonen J, Rintamäki H, Salaspuro M, Lindqvist C, Meurman JH (2001) Poor dental status increases the acetaldehyde production from ethanol in saliva: a possible link to the higher risk of oral cancer among alcohol-consumers. Oral Oncol 37:153-158.
13. Ishii H, Joly J-G, Lieber CS (1973) Effect of ethanol on the amount and enzyme activities of hepatic rough and smooth microsomal membranes. Biochim Biophys Acta 291:411-420.
14. Lane BP, Lieber CS (1966) Ultrastructural alterations in human hepatocytes following ingestion of ethanol with adequate diets. Am J Pathol 49:593-603.
15. Leo MA, Aria M, Sato M, Lieber CS (1982) Hepatotoxicity of vitamin A and ethanol in the rat. Gastroenterology 82:194-205.
16. Leo MA, Iida S, Lieber CS (1984) Retinoic acid metabolism by a system reconstituted with cytochrome P-450. Arch Biochem Biophys 234:305-312.
17. Leo MA, Kim CI, Lieber CS (1989a) Role of vitamin A degradation for the control of hepatic levels in the rat. J Nutr 119:993-1000.
18. Leo MA, Kim CI, Lowe N, Lieber CS (1992) Interaction of ethanol with β-carotene: delayed blood clearance and enhanced hepatotoxicity. Hepatology 15:883-891.
19. Leo MA, Lasker JM, Raucy JL, Kim C, Black M, Lieber CS (1989b) Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8. Arch Biochem Biophys 269:305-312.
20. Leo MA, Lieber CS (1982) Hepatic vitamin A depletion in alcoholic liver injury. N Engl J Med 307:597-601.
21. Leo MA, Lieber CS (1983) Hepatic fibrosis after long term administration of ethanol and moderate vitamin A supplementation in the rat. Hepatology 3:1-11.
22. Leo MA, Lieber CS (1985) New pathway for retinol metabolism in liver microsomes. J Bio Chem 260:5228-5231.
23. Leo MA, Lieber CS (1999) Alcohol, vitamin A, beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr 69:1071-1085.
24. Leo MA, Lowe N, Lieber CS (1986) Interaction of drugs and retinol. Biochem Pharmacol 35:3949-3953.
25. Leo MA, Sato M, Lieber CS (1983) Effect of hepatic vitamin A depletion on the liver in humans and rats. Gastroenterology 84:562-572.
26. Li JJ, Kim CI, Leo MA, Mak KM, Rojkind M, Lieber CS (1992) Polyunsaturated lecithin prevents acetaldehyde-mediated hepatic collagen accumulation by stimulating collagenase activity in cultured lipocytes. Hepatology 15:373-381.
27. Lieber CS (1997) Cytochrome P4502E1: its physiological and pathological role. Physiol Rev 77:517-544.
28. Lieber CS, Baraona E, Hernandez-Munoz R, Kubota S, Sato N, Kawano S, Matsumura T, Inatomi N (1989) Impaired oxygen utilization: a new mechanism for the hepatotoxicity of ethanol in sub-human primates. J Clin Invest 83:1682-1690.
29. Lieber CS, Casini A, DeCarli LM, Kim C, Lowe N, Sasaki R, Leo MA (1990a) S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology 11:165-172.
30. Lieber CS, Davidson CS (1962) Some metabolic effects of ethyl alcohol. Am J Med 33:319-327.
31. Lieber CS, DeCarli LM (1968) Ethanol oxidation by hepatic microsomes: adaptive increase after ethanol feeding. Science 162:917-918.
32. Lieber CS, DeCarli LM (1970) Hepatic microsomal ethanol oxidizing system: in vitro characteristics and adaptive properties in vivo. J Biol Chem 245:2505-2512.
33. Lieber CS, DeCarli LM, Mak KM, Kim CI, Leo MA (1990b) Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin. Hepatology 12:1390-1398.
34. Lieber CS, Jones DP, Mendelson J, DeCarli LM (1963) Fatty liver, hyperlipemia and hyperuricemia produced by prolonged alcohol consumption, despite adequate dietary intake. Trans Assoc Am Physicians 76:289-300.
35. Lieber CS, Leo MA, Aleynik SI, Aleynik MK, DeCarli LM (1997) Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the baboon. Alcohol Clin Exp Res 21:375-379.
36. Lieber CS, Robins SJ, Leo MA (1994a) Hepatic phosphatidylethanolamine methyltransferase activity is decreased by ethanol and increased by phosphatidylcholine. Alcohol Clin Exp Res 18:592-595.
37. Lieber CS, Robins SJ, Li J, DeCarli, Mak KM, Fasulo JM, Leo MA (1994b) Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 106:152-159.
38. Lieber CS, Weiss DG, Groszmann R, Paronetto F, Schenker S, for the VA Cooperative Study 391 (2003a) I: VA Cooperative study of polyenylphosphatidylcholine in alcoholic liver disease: effects on drinking behavior by nurse/physician teams. Alcohol Clin Exp Res 27:1757-1764.
39. Lieber CS, Weiss DG, Groszmann R, Paronetto F, Schenker S, for the VA Cooperative Study 391 (2003b) II: VA Cooperative study of polyenylphosphatidylcholine in alcoholic liver disease. Alcohol Clin Exp Res 27:1765-1772.
40. Liisanantti MK, Hannuksela ML, Rämet ME, Savolainen MJ (2004a) Lipoprotein-associated phosphatidylethanol increases the plasma concentration of vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 24:1037-1042.
41. Liisanantti MK, Huhta K, Savolainen MJ (2004b) Transfer of phosphatidylethanol between lipoproteins. Alcohol Exp Clin Res 28:1638-1642.
42. Liisanantti MK, Savolainen MJ (2004c) Phosphatidylethanol in high density lipoproteins increases the vascular endothelial growth factor in smooth muscle cells. Atherosclerosis, in press.
43. Mak KM, Leo MA, Lieber CS (1984) Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells. Gastroenterology 87:188-200.
44. Mato JM, Cámara J, Fernández de Paz J, Caballería L, Coll S, Caballero A, Buey-García L, Beltrán J, Benita V, Caballería J, Solá R, Otero-Moreno R, Fèlix B, Duce-Martin A, Correa JA, Parès A, Barro E, Magaz-García I, Puerta JL, Moreno J, Boissard G, Ortiz P, Rodès J (1999) S-Adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicentre clinical trial. J Hepatol 30:1081-1089.
45. Moshage H (2004) The cirrhotic hepatocyte: navigating between Scylla and Charybdis. J Hepatol 40:1027-1029.
46. Poniachik J, Baraona E, Zhao J, Lieber CS (1999) Dilinoleoylphosphatidylcholine decreases hepatic stellate cells activation. J Lab Clin Med 133:342-348.
47. Roncucci L, Di Donato P, Carati L, Ferrari A, Perini M, Bertoni G, Bedogni G, Paris B, Svanoni F, Girola M (1993) Antioxidant vitamins or lactulose for prevention of the recurrence of colorectal adenomas. Dis Colon Rectum 36:227-234.
48. Salaspuro M (2003) Acetaldehyde, microbes, and cancer of the digestive tract. Crit Rev Clin Lab Med 40:183-208.
49. Salaspuro V, Hietala J, Kaihovaara P, Pihlajarinne L, Marvola M, Salaspuro M (2002) Removal of acetaldehyde from saliva by a slow-release buccal tablet of cysteine. Int J Cancer 97:361-364.
50. Salaspuro V, Salaspuro M (2004) Synergistic effect of alcohol drinking and smoking on in vivo acetaldehyde concentration in saliva. Int J Cancer 111:480-483.
51. Sato M, Lieber CS (1981) Hepatic vitamin A depletion after chronic ethanol consumption in baboons and rats. J Nutr 111:2015-2023.
52. Sato M, Lieber CS (1982) Increased metabolism of retinoic acid after chronic ethanol consumption in rat liver microsomes. Arch Biochem Biophys 213:557-564.
53. Savolainen ER, Leo MA, Timpl R, Lieber CS (1984) Acetaldehyde and lactate stimulate collagen synthesis of cultured baboon liver myofibroblasts. Gastroenterology 87:777-787.
54. Schoemaker MH, Conde de la Rosa L, Homan M, Vrenken TE, Havinga R, Poelstra K, Haisma HJ, Jansen PLM, Moshage H (2004) TUDCA protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 39:1563-1573.
55. Schoemaker MH, Gommans WM, Conde de la Rosa L, Homan M, Klok P, Trautwein C, Van Goor H, Poelstra K, Haisma HJ, Jansen PLM, Moshage H (2003) Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to NF-kB activation. J Hepatol 39:153-161.
56. Schoemaker MH, Moshage H (2004) Defying death: the hepatocyte's survival kit. Clin Sci 107:13-25.
57. Seitz HK, Stickel F, Homann N (2004) Pathogenetic mechanisms of upper aerodigestive tract cancer in alcoholics. Int J Cancer 108:483-487.
58. Seth D, Leo MA, McGuinness, Lieber CS, Brennan Y, Williams R, Wang XM, McCaughan GW, Gorrell MD, Haber PS (2003) Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver. Am J Pathol 163:2303-2317.
59. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW (2001) Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut 49:465-576.
60. Teschke R, Hasumura Y, Joly JG, Ishii H, Lieber CS (1972) Microsomal ethanol-oxidizing system (MEOS): purification and properties of a rat liver system free of catalase and alcohol dehydrogenase. Biochem Biophys Res Commun 49:1187-1193.
61. Teschke R, Hasumura Y, Liebe, CS (1974) Hepatic microsomal ethanol-oxiding system: solubilization, isolation and characterization. Arch Biochem Biophys 163:404-415.
62. Väkeväinen S, Tillonen J, Agarwal DP, Srivastava N, Salaspuro M (2000) High salivary acetaldehyde after a moderate dose of alcohol in ALDH2-deficient subjects: strong evidence for the local carcinogenic action of acetaldehyde. Alcohol Clin Exp Res 24:873-877.
63. Väkeväinen S, Tillonen J, Salaspuro M (2001) 4-Methylpyrazole decreases salivary acetaldehyde levels in ALDH2-deficient subjects but not in subjects with normal ALDH2. Alcohol Clin Exp Res 25:829-834.
64. Visapää J-P, Götte K, Benesova M, Li J, Homann N, Conradt C, Inoue H, Tisch M, Hörrmann K, Väkeväinen S, Salaspuro M, Seitz HK (2004) Increased cancer risk in heavy drinkers with the alcohol dehydrogenase 1C*1 allele, possibly due to salivary acetaldehyde. Gut 53:871-876.
65. Yokoyama A, Muramatsu T, Ohmori T, Yokoyama T, Okuyama K, Takahashi H, Hasegawa Y, Higuchi S, Muruyama K, Shirakura K, Ishii H (1998) Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis 19:1383-1387.
66. Zidi HZ, Linderborg K, Väkeväinen S, Salaspuro M, Jokelainen K (2003) Lactulose reduces intracolonic acetaldehyde concentration and ethanol elimination rate in rats. Alcohol Clin Exp Res 27:1459-1462.